1. Home
  2. INBX vs KVAC Comparison

INBX vs KVAC Comparison

Compare INBX & KVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INBX
  • KVAC
  • Stock Information
  • Founded
  • INBX 2010
  • KVAC 2021
  • Country
  • INBX United States
  • KVAC United States
  • Employees
  • INBX N/A
  • KVAC N/A
  • Industry
  • INBX Biotechnology: Pharmaceutical Preparations
  • KVAC
  • Sector
  • INBX Health Care
  • KVAC
  • Exchange
  • INBX Nasdaq
  • KVAC Nasdaq
  • Market Cap
  • INBX 218.9M
  • KVAC 212.1M
  • IPO Year
  • INBX 2020
  • KVAC 2023
  • Fundamental
  • Price
  • INBX $14.19
  • KVAC $11.02
  • Analyst Decision
  • INBX Hold
  • KVAC
  • Analyst Count
  • INBX 1
  • KVAC 0
  • Target Price
  • INBX N/A
  • KVAC N/A
  • AVG Volume (30 Days)
  • INBX 80.6K
  • KVAC 15.5K
  • Earning Date
  • INBX 11-14-2024
  • KVAC 01-01-0001
  • Dividend Yield
  • INBX N/A
  • KVAC N/A
  • EPS Growth
  • INBX N/A
  • KVAC N/A
  • EPS
  • INBX 119.38
  • KVAC 0.43
  • Revenue
  • INBX $1,568,000.00
  • KVAC N/A
  • Revenue This Year
  • INBX N/A
  • KVAC N/A
  • Revenue Next Year
  • INBX N/A
  • KVAC N/A
  • P/E Ratio
  • INBX $0.11
  • KVAC $25.54
  • Revenue Growth
  • INBX 19.24
  • KVAC N/A
  • 52 Week Low
  • INBX $10.80
  • KVAC $10.37
  • 52 Week High
  • INBX $18.95
  • KVAC $11.02
  • Technical
  • Relative Strength Index (RSI)
  • INBX 47.10
  • KVAC 80.28
  • Support Level
  • INBX $12.51
  • KVAC $10.94
  • Resistance Level
  • INBX $14.86
  • KVAC $10.99
  • Average True Range (ATR)
  • INBX 1.05
  • KVAC 0.00
  • MACD
  • INBX -0.14
  • KVAC -0.00
  • Stochastic Oscillator
  • INBX 38.89
  • KVAC 100.00

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

About KVAC Keen Vision Acquisition Corporation

Keen Vision Acquisition Corp is a blank check company.

Share on Social Networks: